We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ABPI Suspends Astellas UK for ‘Serious Breaches’ of Conduct
ABPI Suspends Astellas UK for ‘Serious Breaches’ of Conduct
The Association of the British Pharmaceutical Industry has suspended Astellas UK from the trade group, citing “serious breaches” of the group’s Code of Practice for the Pharmaceutical Industry.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor